Evaluating a Novel Immunotherapy in Dogs with Osteosarcoma
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.
Researchers will investigate if the calcium concentration in urine can be used as a non-invasive marker of calcium oxalate bladder stones in miniature schnauzers.
Researchers are characterizing the fecal microbiome of a defined group of golden retrievers.
Researchers will identify horse breeds most susceptible to Salmonella and determine which antibiotics would provide the greatest benefit to stricken animals.
Researchers will search for genetic markers associated with an increased risk for equine metabolic syndrome, a disorder in horses characterized by insulin resistance, obesity and susceptibility to laminitis.
Researchers will evaluate a new culture technique to grow stem cells less likely to be rejected by the patient during treatment.
Researchers will investigate a promising new treatment target for equine asthma.
Researchers will determine how long infected horses shed Salmonella in their feces and use this new information to improve infection prevention and control.
As part of a larger research project (D17EQ-019), the research fellow will analyze metabolic products to help prioritize genetic regions of interest in the ongoing search for markers associated with an increased risk of equine metabolic syndrome in horses.
Researchers will evaluate genes associated with squamous cell carcinoma – a common cancer in horses affecting the eye area – to gauge their value as new therapeutic targets and their use in early cancer detection.